Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Net Debt Over TimeElevated
Percentile Rank80
5Y CAGR-23.5%
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

5Y CAGR
-23.5%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
2024$25.95M+7.1%
2023$24.23M+655.7%
2022$3.21M+102.7%
2021$-117.45M-69.5%
2020$-69.29M-170.0%
2019$98.97M-